Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Total Brain Limited
  6. News
  7. Summary
    TTB   AU0000032435

TOTAL BRAIN LIMITED

(TTB)
  Report
Delayed Australian Stock Exchange  -  08:08 2022-09-28 pm EDT
0.0470 AUD   +4.44%
08/30Total Brain Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/05Total Brain Agrees to Salell Business for $10 Million
MT
08/05SonderMind Inc. entered into an agreement to acquire Assets of Total Brain Limited for $10 million.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SonderMind Inc. entered into an agreement to acquire Assets of Total Brain Limited for $10 million.

08/05/2022 EDT

SonderMind Inc. entered into an agreement to acquire Assets of Total Brain Limited for $10 million on August 5, 2022. An additional payment of $3 million may become payable on completion if the Company implements a previously executed clinical services agreement with one of its key customers by August 22, 2022. This would require the commencement of the Company's platform being made available to the client's patients on terms acceptable to SonderMind. The payment is not pro rated and there is no guarantee TTB will become entitled to this payment. A summary of the Agreement is set out in Annexure A to this announcement. The Agreement contains customary exclusivity obligations for a public company transaction which are set out in full in Annexure B to this announcement.The TTB Board intends to use the purchase consideration to: • pay transaction fees;• pay outstanding liabilities of the TTB Group, including the convertible note to Zoltan Varga;2 and• following these payments, conduct a share buy-back enabling shareholders to liquidate their investment in the Company. The Proposed Transaction is subject to a number of conditions (Conditions) which must be satisfied or waived for completion to occur, including:• approval of the Proposed Transaction by TTB shareholders by ordinary resolution in accordance with ASX Listing Rule 11.2;• no breach of warranty by SonderMind;• no breach of warranty by the TTB Group• no material adverse change occurring in relation to the TTB Group;• receipt of material third party consents to assign or novate contracts to SonderMind;• no insolvency event occurring in respect of any member of the TTB Group;• key employees accepting employment with SonderMind; and• agreement of the terms on which interim funding is provided by SonderMind to the TTB Group. The transactionis expected to be completed by late September 2022.


© S&P Capital IQ 2022
All news about TOTAL BRAIN LIMITED
08/30Total Brain Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/05Total Brain Agrees to Salell Business for $10 Million
MT
08/05SonderMind Inc. entered into an agreement to acquire Assets of Total Brain Limited for ..
CI
06/02Total Brain : Application for quotation of securities - TTB
PU
06/02Total Brain Limited announced that it expects to receive AUD 0.0396 million in funding
CI
05/26VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to ..
CI
05/20Total Brain : Dr. Evian Gordon, Chief Medical Officer, Total Brain, to Address the Role of..
PU
05/10Total Brain Limited Announces 5-Year Extension of AARP Contract
CI
05/03Transcript : Total Brain Limited, Q3 2022 Earnings Call, May 04, 2022
CI
04/10Total Brain : Notification regarding unquoted securities - TTB
PU
More news
Financials
Sales 2022 9,80 M 6,35 M 6,35 M
Net income 2022 -4,00 M -2,59 M -2,59 M
Net Debt 2022 2,36 M 1,53 M 1,53 M
P/E ratio 2022 -1,64x
Yield 2022 -
Capitalization 6,28 M 4,07 M 4,07 M
EV / Sales 2022 0,88x
EV / Sales 2023 0,60x
Nbr of Employees 29
Free-Float 59,3%
Chart TOTAL BRAIN LIMITED
Duration : Period :
Total Brain Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TOTAL BRAIN LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 0,05
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Matthew Mund Chief Executive & Operating Officer
Evian Gordon Executive Chairman & Chief Medical Officer
Donna Palmer Chief Science Officer
Matthew Morgan Non-Executive Director
David Torrible Non-Executive Director